Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
$225 million to be invested into Cincinnati facility to increase PFS and Cartridge fill/finish capabilities Expanding Research Triangle Park (RTP)...
NEWS
Read on
National Resilience and Taiwan Bio-Manufacturing Corporation Announce Groundbreaking Partnership in Biomanufacturing Innovation
Taipei, Taiwan and San Diego, California, February 5, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company...
Resilience Announces Expansion in West Chester
Project will create 440 new jobs and include further development of Resilience’s West Chester biomanufacturing site
Resilience Appoints Bill Marth as President of Services
National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today...
BridgeBio and Resilience Announce Strategic Multi-Year Partnership
Resilience to manufacture BridgeBio’s lead investigational gene therapy treatments, BBP-631 and BBP-812 Partnership provides an innovative, capital...
Resilience Announces Joint Venture with Lifera in Saudi Arabia
The joint venture with Lifera would build an advanced large-scale, commercial drug product manufacturing facility in Riyadh, Saudi Arabia Resilience...
